A 60-year-old man with type 2 diabetes on metformin and insulin presents with 3 days of nausea, vomiting, and diffuse abdominal pain. He appears ill and confused. Vital signs: BP 95/60 mmHg, HR 115/min, RR 28/min, T 37.2°C. Labs show glucose 380 mg/dL, pH 7.28, HCO3 18 mEq/L, anion gap 24, serum osmolality 310 mOsm/kg, negative urine ketones, creatinine 2.8 mg/dL (baseline 1.1), lactate 8.2 mmol/L. Apply physiological principles to determine the primary acid-base and metabolic disturbance.
Q2
A 38-year-old woman presents with hypertension (170/105 mmHg), hypokalemia (2.9 mEq/L), and metabolic alkalosis. Plasma aldosterone is elevated at 35 ng/dL (normal 4-31) and plasma renin activity is suppressed at 0.2 ng/mL/hr (normal 0.5-3.5). CT scan shows a 2.5 cm left adrenal mass. She also reports recent diagnosis of hyperthyroidism and is being evaluated for a neck mass. Synthesize these findings to evaluate for an underlying unifying diagnosis requiring modified treatment approach.
Q3
A 32-year-old pregnant woman at 28 weeks gestation with type 1 diabetes presents with recurrent severe hypoglycemia despite reducing her insulin dose. Her insulin requirements have decreased by 40% over the past week. She reports decreased fetal movement. Fetal ultrasound shows intrauterine fetal demise. Evaluate the physiological mechanism explaining her changing insulin requirements in the context of pregnancy loss.
Q4
A 55-year-old man with type 1 diabetes for 30 years is hospitalized for pneumonia. Despite appropriate antibiotic therapy, his insulin requirements have tripled. Blood glucose ranges from 250-400 mg/dL. He develops hypotension unresponsive to fluid resuscitation. Cortisol level is 2 μg/dL (normal 5-25), and ACTH is 320 pg/mL (normal 10-60). Evaluate the endocrine complication and synthesize the pathophysiological connection to his primary disease.
Q5
A 42-year-old woman presents with tremor, anxiety, and weight loss. TSH is 0.02 mIU/L, free T4 is 3.2 ng/dL, and T3 is 280 ng/dL (normal 80-180). Radioactive iodine uptake scan shows uniformly increased uptake of 45% at 24 hours (normal 10-30%). Thyroid-stimulating immunoglobulin is positive. Analyze the feedback mechanism disruption occurring in this patient's hypothalamic-pituitary-thyroid axis.
Q6
A 50-year-old man with obesity presents with fatigue, facial rounding, and proximal muscle weakness. Initial screening shows elevated 24-hour urinary free cortisol. Serum cortisol remains elevated after low-dose dexamethasone suppression test but suppresses with high-dose dexamethasone. ACTH level is 85 pg/mL (normal 10-60). Analyze these findings to determine the anatomical source of excess cortisol production.
Q7
A 35-year-old woman undergoes total thyroidectomy for papillary thyroid cancer. Two hours post-operatively, she develops perioral numbness and carpopedal spasm. Trousseau's sign is positive. Serum calcium is 6.8 mg/dL (normal 8.5-10.5). Analyze the pathophysiological mechanism linking the surgical procedure to her current presentation.
Q8
A 28-year-old woman with Addison's disease presents to the emergency department with severe vomiting and diarrhea for 2 days. She ran out of her medications 3 days ago. Blood pressure is 85/50 mmHg, heart rate 118/min. Laboratory results show sodium 128 mEq/L, potassium 6.2 mEq/L, glucose 65 mg/dL. Apply your understanding of adrenal physiology to determine the immediate hormonal deficiency causing her presentation.
Q9
A 62-year-old man with type 2 diabetes mellitus presents for routine follow-up. His HbA1c is 8.2% despite metformin and lifestyle modifications. His physician considers adding a GLP-1 receptor agonist. Apply physiological principles to predict the expected effects of this medication on his glucose homeostasis.
Q10
A 45-year-old woman presents with heat intolerance, palpitations, and weight loss despite increased appetite. Physical examination reveals a diffusely enlarged thyroid gland, warm moist skin, and fine tremor. Laboratory tests show TSH <0.01 mIU/L (normal 0.5-5.0), free T4 4.5 ng/dL (normal 0.9-1.7), and positive TSH receptor antibodies. She is started on methimazole. Apply your knowledge of thyroid physiology to explain the mechanism by which this medication will restore euthyroid state.
Endocrine system (thyroid, adrenal, pancreas) US Medical PG Practice Questions and MCQs
Question 1: A 60-year-old man with type 2 diabetes on metformin and insulin presents with 3 days of nausea, vomiting, and diffuse abdominal pain. He appears ill and confused. Vital signs: BP 95/60 mmHg, HR 115/min, RR 28/min, T 37.2°C. Labs show glucose 380 mg/dL, pH 7.28, HCO3 18 mEq/L, anion gap 24, serum osmolality 310 mOsm/kg, negative urine ketones, creatinine 2.8 mg/dL (baseline 1.1), lactate 8.2 mmol/L. Apply physiological principles to determine the primary acid-base and metabolic disturbance.
A. Sepsis-induced lactic acidosis with stress hyperglycemia
B. Hyperosmolar hyperglycemic state complicated by lactic acidosis from metformin (Correct Answer)
C. Alcoholic ketoacidosis with concurrent diabetic emergency
D. Diabetic ketoacidosis with renal failure from volume depletion
E. Mixed metabolic acidosis from uremia and starvation ketosis
Explanation: ***Hyperosmolar hyperglycemic state complicated by lactic acidosis from metformin***
- The patient exhibits features of **Hyperosmolar Hyperglycemic State (HHS)**, including significant hyperglycemia and confusion, but the **negative urine ketones** effectively rule out DKA.
- The severe **high anion gap metabolic acidosis** is driven by a **lactate of 8.2 mmol/L**, likely due to **Metformin-Associated Lactic Acidosis (MALA)** triggered by **acute kidney injury** (creatinine 2.8).
*Sepsis-induced lactic acidosis with stress hyperglycemia*
- While the patient is hypotensive and tachycardic, the **serum glucose of 380 mg/dL** and history of insulin use point primarily to a diabetic emergency rather than simple stress hyperglycemia.
- **Lactic acidosis** in sepsis usually occurs alongside clinical signs of infection, which are not the focus of this metformin-using patient's profile.
*Alcoholic ketoacidosis with concurrent diabetic emergency*
- **Alcoholic ketoacidosis** would typically present with a history of alcohol abuse and **positive ketones** (specifically beta-hydroxybutyrate), which contradicts the **negative urine ketones** found here.
- The primary source of acidosis in this patient is clearly identified as **lactate (8.2 mmol/L)**, not ketoacids.
*Diabetic ketoacidosis with renal failure from volume depletion*
- **Diabetic Ketoacidosis (DKA)** is unlikely given the **negative urine ketones** and a pH/bicarbonate profile that is less severe than typically seen in profound ketoacidosis.
- DKA usually presents with a lower glucose level (often <250-300 mg/dL) compared to the hyperosmolar states seen in **Type 2 Diabetes** patients.
*Mixed metabolic acidosis from uremia and starvation ketosis*
- While **uremia** contributes to the anion gap when creatinine is elevated (2.8 mg/dL), it is rarely the primary cause of an **anion gap of 24** without more advanced renal failure.
- **Starvation ketosis** would result in positive ketones and a much milder acidosis than the profound **lactic acidosis** (8.2 mmol/L) observed in this case.
Question 2: A 38-year-old woman presents with hypertension (170/105 mmHg), hypokalemia (2.9 mEq/L), and metabolic alkalosis. Plasma aldosterone is elevated at 35 ng/dL (normal 4-31) and plasma renin activity is suppressed at 0.2 ng/mL/hr (normal 0.5-3.5). CT scan shows a 2.5 cm left adrenal mass. She also reports recent diagnosis of hyperthyroidism and is being evaluated for a neck mass. Synthesize these findings to evaluate for an underlying unifying diagnosis requiring modified treatment approach.
A. Ectopic ACTH syndrome from thyroid carcinoma causing bilateral adrenal hyperplasia
B. Multiple endocrine neoplasia type 2 requiring RET proto-oncogene testing and comprehensive screening (Correct Answer)
C. Carney complex requiring cardiac myxoma screening before adrenal surgery
D. Isolated aldosterone-producing adenoma requiring unilateral adrenalectomy only
E. Coincidental adrenal adenoma and Graves' disease requiring separate standard treatments
Explanation: ***Multiple endocrine neoplasia type 2 requiring RET proto-oncogene testing and comprehensive screening***
- The presence of an **adrenal mass** and a **neck mass** in a relatively young patient with hypertension points toward **Multiple Endocrine Neoplasia type 2 (MEN 2)**, specifically medullary thyroid cancer and potential pheochromocytoma.
- While the labs mimic **primary hyperaldosteronism**, the high-risk combination requires **RET proto-oncogene** testing to identify a syndromic association and prevent surgical catastrophes.
*Ectopic ACTH syndrome from thyroid carcinoma causing bilateral adrenal hyperplasia*
- Ectopic ACTH typically results from **small cell lung cancer** or bronchial carcinoids and presents with **hypercortisolism** (Cushing syndrome), not primary hyperaldosteronism.
- The CT scan specifically identified a **unilateral 2.5 cm mass**, which is inconsistent with the **bilateral adrenal hyperplasia** seen in ACTH-secreting tumors.
*Carney complex requiring cardiac myxoma screening before adrenal surgery*
- Carney complex usually involves **Primary Pigmented Nodular Adrenocortical Disease (PPNAD)**, which presents with Cushing syndrome, not the mineralocorticoid excess seen here.
- This syndrome is characterized by **skin lentigines**, **blue nevi**, and **atrial myxomas**, which are not reported in this patient's clinical presentation.
*Isolated aldosterone-producing adenoma requiring unilateral adrenalectomy only*
- While the **high aldosterone** and **low renin** (ARR > 30) suggest an **aldosteronoma (Conn syndrome)**, this diagnosis does not account for the concurrent thyroid and neck masses.
- Proceeding with surgery based on an isolated diagnosis would be dangerous if the mass is actually a **pheochromocytoma** (common in MEN 2) disguised by confounding labs.
*Coincidental adrenal adenoma and Graves' disease requiring separate standard treatments*
- **Graves' disease** typically presents with a diffuse goiter and ophthalmopathy rather than a discrete **neck mass**, which is more indicative of a thyroid nodule or carcinoma.
- In medical examinations, clusters of endocrine findings are rarely coincidental; assuming they are unrelated misses the opportunity to screen for **hereditary syndromes**.
Question 3: A 32-year-old pregnant woman at 28 weeks gestation with type 1 diabetes presents with recurrent severe hypoglycemia despite reducing her insulin dose. Her insulin requirements have decreased by 40% over the past week. She reports decreased fetal movement. Fetal ultrasound shows intrauterine fetal demise. Evaluate the physiological mechanism explaining her changing insulin requirements in the context of pregnancy loss.
A. Increased maternal growth hormone from pituitary compensation for fetal loss
B. Maternal thyroid hormone surge causing enhanced glucose utilization
C. Loss of placental lactogen and other diabetogenic hormones that normally increase insulin resistance (Correct Answer)
D. Increased maternal cortisol from stress of fetal loss improving insulin sensitivity
E. Placental glucose consumption cessation leading to maternal hyperglycemia compensation
Explanation: ***Loss of placental lactogen and other diabetogenic hormones that normally increase insulin resistance***
- Sudden **intrauterine fetal demise** leads to the cessation of placental function and a rapid drop in **human placental lactogen (hPL)**, which normally promotes maternal **insulin resistance**.
- Without these antagonizing hormones, the patient's **insulin sensitivity** returns to pre-pregnancy levels, causing a dramatic decrease in insulin requirements and severe **hypoglycemia**.
*Increased maternal growth hormone from pituitary compensation for fetal loss*
- Maternal **pituitary growth hormone** is actually suppressed during pregnancy as placental growth hormone takes over; there is no compensatory surge upon fetal loss.
- Even if growth hormone were to increase, it is a **diabetogenic hormone** that would increase insulin resistance rather than cause hypoglycemia.
*Maternal thyroid hormone surge causing enhanced glucose utilization*
- Pregnancy loss does not trigger a maternal **thyroid hormone surge**; thyroid levels typically stabilize or decrease following placental dysfunction.
- While hyperthyroidism can affect metabolism, it more commonly causes **glucose intolerance** rather than a 40% reduction in insulin needs.
*Increased maternal cortisol from stress of fetal loss improving insulin sensitivity*
- **Cortisol** is a stress hormone that increases gluconeogenesis and **decreases insulin sensitivity**, which would lead to hyperglycemia.
- Normal pregnancy is already a state of **physiologic hypercortisolism**; the loss of placental function actually reduces the contributions of placental CRH and cortisol.
*Placental glucose consumption cessation leading to maternal hyperglycemia compensation*
- While the fetus and placenta stop consuming glucose after demise, the loss of **anti-insulin hormones** has a much larger impact on the maternal metabolic state.
- The clinical presentation clearly shows **hypoglycemia**, which contradicts a compensatory mechanism for maternal hyperglycemia.
Question 4: A 55-year-old man with type 1 diabetes for 30 years is hospitalized for pneumonia. Despite appropriate antibiotic therapy, his insulin requirements have tripled. Blood glucose ranges from 250-400 mg/dL. He develops hypotension unresponsive to fluid resuscitation. Cortisol level is 2 μg/dL (normal 5-25), and ACTH is 320 pg/mL (normal 10-60). Evaluate the endocrine complication and synthesize the pathophysiological connection to his primary disease.
A. Isolated aldosterone deficiency from diabetic nephropathy
B. Medication-induced suppression of adrenal function from chronic steroid use
C. Sepsis-induced adrenal hemorrhage causing acute adrenal crisis
D. Autoimmune polyglandular syndrome type 2 with adrenal insufficiency complicating stress response (Correct Answer)
E. Pituitary apoplexy from infection causing secondary adrenal insufficiency
Explanation: ***Autoimmune polyglandular syndrome type 2 with adrenal insufficiency complicating stress response***
- This patient demonstrates **Primary Adrenal Insufficiency** indicated by a low **cortisol (2 μg/dL)** and high **ACTH (320 pg/mL)**, which is associated with **Type 1 Diabetes** as part of **APS Type 2 (Schmidt Syndrome)**.
- The **refractory hypotension** during pneumonia signifies an **addisonian crisis**, where the loss of cortisol prevents the maintenance of **vascular tone** required for a normal stress response.
*Isolated aldosterone deficiency from diabetic nephropathy*
- While **hyporeninemic hypoaldosteronism** can occur in diabetes, it would not explain the significantly low **cortisol levels** or the high **ACTH** levels seen here.
- This condition typically presents with **hyperkalemia** and mild metabolic acidosis, rather than profound **hypotensive shock** unresponsive to fluids.
*Medication-induced suppression of adrenal function from chronic steroid use*
- Chronic steroid use causes **secondary adrenal insufficiency**, which is characterized by both low cortisol and **low ACTH** due to feedback suppression.
- In this case, the **elevated ACTH** confirms the defect is at the level of the adrenal gland, not the hypothalamus or pituitary.
*Sepsis-induced adrenal hemorrhage causing acute adrenal crisis*
- Known as **Waterhouse-Friderichsen syndrome**, this is typically an acute destruction related to **meningococcemia** rather than a long-term autoimmune association.
- While it causes primary insufficiency, the long history of **Type 1 Diabetes** makes an **autoimmune polyendocrine** etiology more probable than a sudden vascular event from pneumonia.
*Pituitary apoplexy from infection causing secondary adrenal insufficiency*
- Pituitary apoplexy usually presents with **sudden severe headache**, visual field defects, and signs of **ACTH deficiency** leading to low cortisol.
- The **high ACTH** (320 pg/mL) in this patient directly contradicts a diagnosis of pituitary failure, as the pituitary is clearly overproducing ACTH to compensate for low cortisol.
Question 5: A 42-year-old woman presents with tremor, anxiety, and weight loss. TSH is 0.02 mIU/L, free T4 is 3.2 ng/dL, and T3 is 280 ng/dL (normal 80-180). Radioactive iodine uptake scan shows uniformly increased uptake of 45% at 24 hours (normal 10-30%). Thyroid-stimulating immunoglobulin is positive. Analyze the feedback mechanism disruption occurring in this patient's hypothalamic-pituitary-thyroid axis.
A. Defective thyroid hormone receptor in the pituitary causing inappropriate TSH release
B. Pituitary adenoma autonomously secreting TSH despite elevated thyroid hormones
C. Antibody-mediated TSH receptor activation bypassing normal feedback inhibition (Correct Answer)
D. Loss of negative feedback at the hypothalamus causing increased TRH secretion
E. Peripheral resistance to thyroid hormone at target tissues requiring higher levels
Explanation: ***Antibody-mediated TSH receptor activation bypassing normal feedback inhibition***
- In **Graves' disease**, **thyroid-stimulating immunoglobulins (TSI)** act as agonists at the **TSH receptor**, stimulating the production of T3 and T4 independently of the pituitary gland.
- While the elevated thyroid hormones exert appropriate **negative feedback** to suppress pituitary **TSH** (explaining the low TSH), they cannot suppress the TSI antibodies, resulting in autonomous thyroid hyperfunction.
*Defective thyroid hormone receptor in the pituitary causing inappropriate TSH release*
- This describes a variant of **Thyroid Hormone Resistance**, which would present with elevated thyroid hormones but **inappropriately normal or high TSH** levels.
- The patient’s TSH is appropriately suppressed (0.02 mIU/L), indicating the pituitary feedback mechanism is intact but overridden by external stimulation.
*Pituitary adenoma autonomously secreting TSH despite elevated thyroid hormones*
- A **TSH-secreting pituitary adenoma** (TSHoma) would lead to high T4 and T3 levels accompanied by a **high or inappropriately normal TSH**.
- This diagnosis is excluded here because the patient's TSH is profoundly suppressed, showing the gland is responding to the high hormone levels.
*Loss of negative feedback at the hypothalamus causing increased TRH secretion*
- If negative feedback were lost, levels of **TRH** and subsequently **TSH** would be elevated, which contradicts the laboratory finding of a suppressed TSH.
- This scenario does not align with the presence of **thyroid-stimulating immunoglobulins**, which are the hallmark of primary autoimmune hyperthyroidism.
*Peripheral resistance to thyroid hormone at target tissues requiring higher levels*
- **Resistance to thyroid hormone (RTH)** typically presents with high free T4 and T3 safely balanced by a **non-suppressed TSH**, often without the typical symptoms of thyrotoxicosis.
- The patient’s clinical symptoms of **weight loss** and **tremor** indicate that peripheral tissues are highly sensitive and responding to the excessive hormone levels.
Question 6: A 50-year-old man with obesity presents with fatigue, facial rounding, and proximal muscle weakness. Initial screening shows elevated 24-hour urinary free cortisol. Serum cortisol remains elevated after low-dose dexamethasone suppression test but suppresses with high-dose dexamethasone. ACTH level is 85 pg/mL (normal 10-60). Analyze these findings to determine the anatomical source of excess cortisol production.
A. Exogenous glucocorticoid administration
B. Primary adrenal hyperplasia independent of ACTH
C. Pituitary adenoma producing excess ACTH (Correct Answer)
D. Ectopic ACTH production from small cell lung cancer
E. Adrenal adenoma with autonomous cortisol secretion
Explanation: ***Pituitary adenoma producing excess ACTH***
- In **Cushing's disease**, the **pituitary adenoma** retains partial sensitivity to negative feedback, which is why cortisol levels suppress with a **high-dose dexamethasone suppression test (HDDST)**.
- The **elevated ACTH** (85 pg/mL) confirms an **ACTH-dependent** etiology, distinguishing it from primary adrenal sources.
*Exogenous glucocorticoid administration*
- Factitious or therapeutic steroid use results in **low (suppressed) ACTH** levels due to strong negative feedback on the pituitary.
- This patient presents with **elevated ACTH**, which is incompatible with exogenous corticosteroid intake.
*Primary adrenal hyperplasia independent of ACTH*
- This condition involves autonomous cortisol production by the **adrenal glands**, leading to the **suppression of ACTH**.
- Since this patient has high ACTH, the pathology must be **ACTH-dependent**, ruling out primary adrenal hyperplasia.
*Ectopic ACTH production from small cell lung cancer*
- **Ectopic ACTH secretion** typically fails to suppress during an **HDDST** because the non-pituitary tumors usually lack glucocorticoid receptors.
- These cases often present with significantly **higher ACTH levels** and more rapid onset of symptoms compared to pituitary-driven disease.
*Adrenal adenoma with autonomous cortisol secretion*
- **Adrenal adenomas** produce cortisol independently of the pituitary, which causes a characteristically **low or undetectable ACTH** level.
- Because the source is the adrenal gland itself, these tumors do not show suppression with **low or high doses of dexamethasone**.
Question 7: A 35-year-old woman undergoes total thyroidectomy for papillary thyroid cancer. Two hours post-operatively, she develops perioral numbness and carpopedal spasm. Trousseau's sign is positive. Serum calcium is 6.8 mg/dL (normal 8.5-10.5). Analyze the pathophysiological mechanism linking the surgical procedure to her current presentation.
A. Acute vitamin D deficiency from loss of thyroid conversion enzymes
B. Postoperative hypomagnesemia causing functional hypoparathyroidism
C. Inadvertent removal of parathyroid glands causing decreased PTH and impaired calcium mobilization (Correct Answer)
D. Surgical stress-induced calcitonin release causing calcium deposition in bone
E. Thyroid hormone withdrawal causing decreased intestinal calcium absorption
Explanation: ***Inadvertent removal of parathyroid glands causing decreased PTH and impaired calcium mobilization***
- Immediate postoperative hypocalcemia following total thyroidectomy is most commonly caused by iatrogenic **hypoparathyroidism** due to accidental removal or devascularization of the **parathyroid glands**.
- Low **Parathyroid Hormone (PTH)** levels lead to decreased renal calcium reabsorption and impaired mobilization of calcium from bone, resulting in **neuromuscular irritability** like **Trousseau’s sign**.
*Acute vitamin D deficiency from loss of thyroid conversion enzymes*
- Vitamin D activation (hydroxylation to 1,25-(OH)₂D) occurs primarily in the **kidneys** and **liver**, not the thyroid gland.
- Acute deficiency would not manifest within two hours of surgery as vitamin D is a **fat-soluble vitamin** with significant body stores.
*Postoperative hypomagnesemia causing functional hypoparathyroidism*
- While **hypomagnesemia** can impair PTH secretion, it is not a direct consequence of the surgical procedure of thyroidectomy itself.
- The clinical context of extensive neck dissection for **papillary thyroid cancer** makes direct **parathyroid injury** a far more likely primary cause.
*Surgical stress-induced calcitonin release causing calcium deposition in bone*
- **Calcitonin**, produced by parafollicular C-cells of the thyroid, has a very weak effect on acute calcium homeostasis in adult humans.
- Even a surge in calcitonin would not typically cause profound symptomatic hypocalcemia with **carpopedal spasms**.
*Thyroid hormone withdrawal causing decreased intestinal calcium absorption*
- The half-life of **Thyroxine (T4)** is approximately 7 days; therefore, acute withdrawal effects do not manifest within hours of surgery.
- Chronic **hypothyroidism** can affect metabolism, but it is not the mechanism for acute postoperative **tetany**.
Question 8: A 28-year-old woman with Addison's disease presents to the emergency department with severe vomiting and diarrhea for 2 days. She ran out of her medications 3 days ago. Blood pressure is 85/50 mmHg, heart rate 118/min. Laboratory results show sodium 128 mEq/L, potassium 6.2 mEq/L, glucose 65 mg/dL. Apply your understanding of adrenal physiology to determine the immediate hormonal deficiency causing her presentation.
A. ACTH excess causing direct renal sodium wasting
B. Isolated cortisol deficiency with intact mineralocorticoid function
C. Isolated aldosterone deficiency causing electrolyte abnormalities only
D. Combined cortisol and aldosterone deficiency with loss of mineralocorticoid and glucocorticoid effects (Correct Answer)
E. Primary epinephrine deficiency from adrenal medulla dysfunction
Explanation: ***Combined cortisol and aldosterone deficiency with loss of mineralocorticoid and glucocorticoid effects***
- **Addison’s disease** involves destruction of the entire **adrenal cortex**, leading to the loss of both **cortisol** and **aldosterone**, which manifests as a life-threatening **adrenal crisis**.
- **Aldosterone deficiency** causes renal sodium wasting and potassium retention (**hyponatremia** and **hyperkalemia**), while **cortisol deficiency** leads to impaired **gluconeogenesis** (hypoglycemia) and vascular collapse.
*ACTH excess causing direct renal sodium wasting*
- While **ACTH** is elevated in primary adrenal insufficiency due to loss of negative feedback, ACTH itself does not cause direct **renal sodium wasting**.
- Sodium wasting is exclusively the result of a lack of **aldosterone** action on the distal tubule and collecting duct.
*Isolated cortisol deficiency with intact mineralocorticoid function*
- This profile is characteristic of **secondary adrenal insufficiency** (pituitary failure), where the **Renin-Angiotensin-Aldosterone System (RAAS)** remains intact.
- In **Addison's disease**, the **zona glomerulosa** is destroyed, so mineralocorticoid function cannot be preserved.
*Isolated aldosterone deficiency causing electrolyte abnormalities only*
- While aldosterone deficiency explains the **hyponatremia** and **hyperkalemia**, it does not account for the **hypoglycemia** seen in this patient.
- **Glucocorticoid deficiency** is required to explain the metabolic disturbances and the severity of the **hypotension** via reduced vascular sensitivity to catecholamines.
*Primary epinephrine deficiency from adrenal medulla dysfunction*
- **Addison's disease** primarily affects the **adrenal cortex**; the **adrenal medulla** is typically spared and is not the cause of clinical adrenal crisis.
- Epinephrine deficiency does not cause **hyperkalemia** or significant **hyponatremia**, which are the hallmark electrolyte findings in this case.
Question 9: A 62-year-old man with type 2 diabetes mellitus presents for routine follow-up. His HbA1c is 8.2% despite metformin and lifestyle modifications. His physician considers adding a GLP-1 receptor agonist. Apply physiological principles to predict the expected effects of this medication on his glucose homeostasis.
A. Inhibition of renal glucose reabsorption at the proximal tubule
B. Direct stimulation of peripheral glucose uptake via GLUT4 translocation
C. Increased insulin secretion independent of glucose levels with decreased glucagon
D. Glucose-dependent insulin secretion, decreased glucagon, and delayed gastric emptying (Correct Answer)
E. Enhanced hepatic glucose uptake through GLUT2 upregulation
Explanation: ***Glucose-dependent insulin secretion, decreased glucagon, and delayed gastric emptying***
- **GLP-1 receptor agonists** work through the **incretin effect**, which stimulates the release of insulin from pancreatic beta cells only in the presence of elevated blood glucose levels.
- These medications also suppress **glucagon secretion** from alpha cells and slow **gastric emptying**, which contributes to postprandial glucose control and weight loss.
*Inhibition of renal glucose reabsorption at the proximal tubule*
- This mechanism of action describes **SGLT2 inhibitors**, not GLP-1 receptor agonists.
- GLP-1 agonists do not have a primary physiological effect on renal **glucose transporters** to lower blood sugar.
*Direct stimulation of peripheral glucose uptake via GLUT4 translocation*
- **GLUT4 translocation** is primarily stimulated by **insulin** acting on muscle and adipose tissue, not directly by GLP-1 agonists.
- While GLP-1 agonists increase insulin, they do not act as direct **insulin mimetics** at the GLUT4 receptor site.
*Increased insulin secretion independent of glucose levels with decreased glucagon*
- Unlike **sulfonylureas**, GLP-1 agonists provide **glucose-dependent** insulin secretion, which significantly lowers the risk of **hypoglycemia**.
- The mechanism requires the presence of glucose to trigger the **cAMP pathway** in beta cells for insulin release.
*Enhanced hepatic glucose uptake through GLUT2 upregulation*
- **GLUT2** is a bidirectional transporter in the liver that is not the primary target for the pharmacological effects of GLP-1 receptor agonists.
- GLP-1 agonists reduce **hepatic glucose production** indirectly by altering the **insulin-to-glucagon ratio**, rather than upregulating glucose uptake transporters.
Question 10: A 45-year-old woman presents with heat intolerance, palpitations, and weight loss despite increased appetite. Physical examination reveals a diffusely enlarged thyroid gland, warm moist skin, and fine tremor. Laboratory tests show TSH <0.01 mIU/L (normal 0.5-5.0), free T4 4.5 ng/dL (normal 0.9-1.7), and positive TSH receptor antibodies. She is started on methimazole. Apply your knowledge of thyroid physiology to explain the mechanism by which this medication will restore euthyroid state.
A. Enhances hepatic metabolism of circulating thyroid hormones
B. Increases peripheral conversion of T4 to reverse T3
C. Blocks iodide uptake by inhibiting the sodium-iodide symporter
D. Inhibits thyroid peroxidase-mediated iodination of thyroglobulin (Correct Answer)
E. Competitively blocks TSH receptors on thyroid follicular cells
Explanation: ***Inhibits thyroid peroxidase-mediated iodination of thyroglobulin***
- **Methimazole** belongs to the thionamide class, which acts by inhibiting the enzyme **thyroid peroxidase (TPO)**.
- This inhibition prevents the **organification** of iodide (iodination of tyrosine residues) and the **coupling** of iodotyrosines, directly reducing the synthesis of new thyroid hormones.
*Enhances hepatic metabolism of circulating thyroid hormones*
- Methimazole does not affect the **metabolic clearance rate** or hepatic breakdown of existing T3 and T4.
- Its primary function is to halt the **production** of hormones within the thyroid gland rather than removing what is already in circulation.
*Increases peripheral conversion of T4 to reverse T3*
- This describes a physiological response to severe illness (**euthyroid sick syndrome**) or certain medications like glucocorticoids, but it is not a mechanism of methimazole.
- While the thionamide **Propylthiouracil (PTU)** inhibits the peripheral conversion of T4 to T3, **methimazole** lacks this specific peripheral effect.
*Blocks iodide uptake by inhibiting the sodium-iodide symporter*
- Inhibition of the **sodium-iodide symporter (NIS)** is the mechanism of competitive anions like **perchlorate** or thiocyanate.
- Methimazole allows iodide to enter the cell but prevents it from being usable for **hormone synthesis** through the TPO pathway.
*Competitively blocks TSH receptors on thyroid follicular cells*
- Methimazole does not act as an **antagonist** at the TSH receptor; it leaves the receptor available for **TSH receptor antibodies** to bind.
- The drug treats the clinical hyperthyroidism by decreasing the **hormonal output** downstream of the receptor activation.
